×
ADVERTISEMENT

FEBRUARY 7, 2018

HIV Drugs in the Pipeline: Expected Approvals for 2018

By Marie Rosenthal

There are about 1.2 million Americans infected with HIV, and about 350,000 of them are not yet receiving treatment, according to Aimee Tharaldson, PharmD, a senior clinical consultant in emerging therapeutics at Express Scripts. 

Integrase strand transfer inhibitor (INSTI)-based regimens are recommended as initial therapy for most people with HIV. Non-nucleoside reverse transcriptase inhibitor (NNRTI)- and protease inhibitor (PI)- based regimens, including darunavir